Annual Drug Patent Expirations for JULUCA
Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
Drug patent litigation for JULUCA.
This drug has four hundred and fifteen patent family members in fifty-three countries.
The generic ingredient in JULUCA is dolutegravir sodium; rilpivirine hydrochloride. One supplier is listed for this compound. Additional details are available on the dolutegravir sodium; rilpivirine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
